Weight Loss Peptides
Research peptides that target appetite regulation, energy expenditure, and fat metabolism. This category covers modern GLP-1 agonists (Tirzepatide, Retatrutide, Mazdutide), the amylin analogue Cagrilintide, and the HGH fragment AOD-9604 — the most-studied compounds in obesity and metabolic research.
Weight Loss Peptides
Retatrutide Pen
from €269.00
Retatrutide is a first-in-class synthetic triple agonist of the GLP-1, GIP, and glucagon receptors, developed by Eli Lilly as the next ev…
Tirzepatide pen
from €209.00
Tirzepatide is a 39-amino-acid synthetic dual agonist of the GLP-1 and GIP receptors, developed by Eli Lilly and approved by the FDA in 2…
Mazdutide
from €119.00
Mazdutide (IBI362, LY3305677) is a synthetic dual agonist of the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor, orig…
Cagrilintide
from €119.00
Cagrilintide is a long-acting synthetic analogue of amylin, a pancreatic hormone co-secreted with insulin by beta cells. Its molecular de…
AOD-9604
from €99.00
AOD-9604 (Anti-Obesity Drug 9604) is a 15-amino-acid synthetic fragment corresponding to the C-terminus of human growth hormone (residues…
Retatrutide
from €129.00
Retatrutide is a first-in-class synthetic triple agonist of the GLP-1, GIP, and glucagon receptors, developed by Eli Lilly as the next ev…
Tirzepatide
from €69.00
Tirzepatide is a 39-amino-acid synthetic dual agonist of the GLP-1 and GIP receptors, developed by Eli Lilly and approved by the FDA in 2…
💬 Комментарии